Hikma Pharmaceuticals Aktie
18,00
EUR
-0,50
EUR
-2,70
%
17,09
CHF
-0,17
CHF
-0,98
%
Werbung
Hikma Pharmaceuticals Aktie Analyse
14.12.12 | Hikma Pharmaceuticals overweight | Morgan Stanley | |
15.10.12 | Hikma Pharmaceuticals overweight | J.P. Morgan Cazenove | |
10.10.11 | Hikma Pharmaceuticals buy | Citigroup Corp. | |
21.07.09 | Hikma Pharmaceuticals | Global Biotech Investing |
Werbung
Werbung